Glycoprotein adhesion receptors such as selectins contribute to tissue inju
ry in stroke. Ischemic neurons strongly expressed C1q, which may target the
m for complement-mediated attack or C1qRp-mediated clearance. A hybrid mole
cule was used to simultaneously inhibit both complement activation and sele
ctin-mediated adhesion. The extracellular domain of soluble complement rece
ptor-1 (sCR1) was sialyl Lewis x glycosylated (sCR1sLe(x)) to inhibit compl
ement activation and endothelial-platelet-Leukocyte interactions. sCR1 and
sCR1sLe(x) colocalized to ischemic cerebral microvessels and C1q-expressing
neurons, inhibited neutrophil and platelet accumulation, and reduced cereb
ral infarct volumes. Additional benefit was conferred by sialyl Lewis x gly
cosylation of the unmodified parent sCR1 molecule.